Results 201 to 210 of about 282,301 (312)

Dream-chasing mindscapes: an inquiry into the psychological change process of postgraduate entrance examination candidates. [PDF]

Front Psychol
Xiaoman C, Zihui L, Juan S.
europepmc   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Caregiver experiences of healthcare-related administrative burden: a scoping review. [PDF]

Health Aff Sch
Thompson T, Krueger DK, Delaney SM, Connelly B, Ghazal LV, Slater VE, Rodriguez B, Thom B.   +7 more
europepmc   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

Understanding Surgeon Engagement with Palliative Care Practices for Seriously Ill Patients: A Qualitative Study. [PDF]

Ann Surg
Morton CR, Reich AJ, Sun W, Dhanani H, Comrie C, Suh L, Farber O, Tabata-Kelly M, Dohan D, Cooper Z.   +9 more
europepmc   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

Exploring the perceived impact of physical activity on physical and mental health among individuals with long COVID: A qualitative interview inquiry. [PDF]

PLoS One
Sirotiak Z, Oberhauser AM, Sirotiak AM, Nettleton KA, Lee DC, Thomas EBK, Brellenthin AG.   +6 more
europepmc   +1 more source

Use of antiemetics in early pregnancy 2012–2022: A cross‐sectional study

British Journal of Clinical Pharmacology, EarlyView.
Aim Nausea and vomiting in pregnancy impact quality of life, yet many pregnant women feel dismissed by healthcare professionals, despite the safety of first‐line antiemetic treatments for both mother and fetus. Therefore, this study aims to describe the prevalence of patient‐reported antiemetic use in early pregnancy in Copenhagen, Denmark, the changes
Katrine Bak Wraae, Nanna Roed Ballegaard, Mie Lærkeholm Hede, Line Buchgreitz, Ane Lilleøre Rom, Hanne Kristine Hegaard, Nina Olsén Nathan   +6 more
wiley   +1 more source

An exploration on unfolding psychological interview for first aid nurses

Huli yanjiu, 2005
沈喜, 杨丽娟, 陈丽君
doaj  

Artificial Intelligence in Anorexia Nervosa Care: Comparing ChatGPT and Google Gemini. [PDF]

Nutrients
Witkowska W, Bzikowska-Jura A.
europepmc   +1 more source